LinkedIn · Mar 2026
PJ Steiner said Ohmic Biosciences is developing disease-resistance traits using protein engineering (and AI) and is looking to speak with breeders and growers about important plant diseases.
Genetically engineering plants for disease resistance.
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
YC S23 ag-biotech startup using protein engineering and synthetic biology to create disease-resistance traits for crops; its first highlighted product is a soybean engineered to resist soybean cyst nematode.
Primary product
Protein-engineered crop disease-resistance traits; first product is SCN-resistant soybean
Founded
2021
Headquarters
Alameda, California, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Agtech / crop tech / crop protection
Offices
0 jobs at Ohmic Biosciences
Check back later for new openings
Business model
Stage
pre-seed
Total raised
$500K
Latest round
Pre-Seed · Sep 2023
Latest amount
$500K
Sep 2023 · Y Combinator
Investors
Differentiators
Technology
Customers
Competitors
LinkedIn · Mar 2026
PJ Steiner said Ohmic Biosciences is developing disease-resistance traits using protein engineering (and AI) and is looking to speak with breeders and growers about important plant diseases.
HireTop · Sep 2023
Third-party article summarizing the company’s crop-disease resistance mission and founder background.
Y Combinator · Jul 2023
YC launch write-up for the company, including its mission, founders, and first product: soybean resistance to soybean cyst nematode.